厚朴 Magnolia Bark Extract

INT-magnolia-bark-001 3 個適應症被研究
C 3

適應症與證據等級

法規與權威立場 (L4)

L4a · US FDA
立場:cautious
The claims on your website establish that these products are drugs under section 201(g)(1) of the FD&C Act ... because they are intended for use in the cure, mitigation, treatment, or prevention of disease and/or intended to affect the structure or any function of the body.
來源 ↗
L4b · EU EFSA
立場:not_addressed
L4c · UK NHS
立場:not_addressed
L4d · TW TFDA / 衛福部
立場:not_addressed
厚朴收載於《臺灣中藥典》,屬中藥材;未列入衛福部中醫藥司公告之「可同時提供食品使用之中藥材」清單。
來源 ↗
L4e · WHO
立場:not_addressed

市場與行銷 (L10)

L10a · TW Market Channels
Relora 舒壓配方 90 顆 約 NT$700
L10b · TW Legal Identity (TFDA)
食品之標示、宣傳或廣告,不得有不實、誇張或易生誤解之情形。食品不得為醫療效能之標示、宣傳或廣告。
L10c · TW Community (PTT/Dcard/Mobile01)